文献速递心血管技术与安全MR

心脏磁共振心肌纤维化与炎症可预测HIV感染者的心血管结局

Myocardial Fibrosis and Inflammation by CMR Predict Cardiovascular Outcome in People Living With HIV.
PubMed 文献 · JACC Cardiovasc Imaging · 2021-04-14

该前瞻性纵向研究纳入156例长期接受HAART治疗的HIV感染者,行CMR评估心肌容积、功能、T1/T2 mapping、灌注及瘢痕。中位随访13个月观察到24例不良心血管事件,事件组原生T1、原生T2、LV质量指数及NT-proBNP均较高,多变量分析显示原生T1独立预测不良事件,传统心血管风险评分无预测价值。

要点

  • HIV感染者CMR原生T1升高与不良心血管事件独立相关,每增加10 ms风险比1.20。
  • 事件组原生T2、LV质量指数及NT-proBNP亦显著高于无事件组。
  • 传统心血管风险评分在该人群中未能预测不良事件。

关键影像表现/征象

  • 事件组原生T1中位数1149 ms(IQR 1115–1163 ms)高于无事件组1110 ms(IQR 1075–1138 ms)。
  • 事件组原生T2中位数40 ms(IQR 38–41 ms)高于无事件组37 ms(IQR 36–39 ms)。
  • 事件组LV质量指数中位数65 g/m2(IQR 49–77 g/m2)高于无事件组57 g/m2(IQR 49–64 g/m2)。
  • 事件组NT-proBNP中位数109 pg/l(IQR 25–337 pg/l)高于无事件组48 pg/l(IQR 23–82 pg/l)。

诊断标准与关键数值

  • 主要终点为裁定不良心血管事件(心血管死亡、非致死性急性冠脉综合征、适当器械放电或记录的心衰住院)。
  • 多变量分析中原生T1独立预测不良事件(卡方检验15.9;p<0.001;每10 ms风险比1.20,95%CI 1.08–1.33;p=0.001)。
  • 包含LV质量的模型卡方检验17.1;p<0.001。
  • 传统心血管风险评分未预测不良事件。

临床应用与阅片要点

  • 对HIV感染者行CMR时,原生T1升高提示弥漫性心肌纤维化,应结合LV质量指数及NT-proBNP综合评估心血管风险。
  • 传统风险评分在此人群预测价值有限,CMR组织 characterization 参数可作为补充风险分层工具。

局限性

  • 单中心前瞻性观察性研究,样本量156例,事件数24例。
  • 随访时间中位13个月,较短。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The goal of this study was to examine prognostic relationships between cardiac imaging measures and cardiovascular outcome in people living with human immunodeficiency virus (HIV) (PLWH) on highly active antiretroviral therapy (HAART).

BACKGROUND: PLWH have a higher prevalence of cardiovascular disease and heart failure (HF) compared with the noninfected population. The pathophysiological drivers of myocardial dysfunction and worse cardiovascular outcome in HIV remain poorly understood.

METHODS: This prospective observational longitudinal study included consecutive PLWH on long-term HAART undergoing cardiac magnetic resonance (CMR) examination for assessment of myocardial volumes and function, T1 and T2 mapping, perfusion, and scar. Time-to-event analysis was performed from the index CMR examination to the first single event per patient. The primary endpoint was an adjudicated adverse cardiovascular event (cardiovascular mortality, nonfatal acute coronary syndrome, an appropriate device discharge, or a documented HF hospitalization).

RESULTS: A total of 156 participants (62% male; age [median, interquartile range]: 50 years [42 to 57 years]) were included. During a median follow-up of 13 months (9 to 19 months), 24 events were observed (4 HF deaths, 1 sudden cardiac death, 2 nonfatal acute myocardial infarction, 1 appropriate device discharge, and 16 HF hospitalizations). Patients with events had higher native T1 (median [interquartile range]: 1,149 ms [1,115 to 1,163 ms] vs. 1,110 ms [1,075 to 1,138 ms]); native T2 (40 ms [38 to 41 ms] vs. 37 ms [36 to 39 ms]); left ventricular (LV) mass index (65 g/m2 [49 to 77 g/m2] vs. 57 g/m2 [49 to 64 g/m2]), and N-terminal pro-B-type natriuretic peptide (109 pg/l [25 to 337 pg/l] vs. 48 pg/l [23 to 82 pg/l]) (all p < 0.05). In multivariable analyses, native T1 was independently predictive of adverse events (chi-square test, 15.9; p < 0.001; native T1 [10 ms] hazard ratio [95% confidence interval]: 1.20 [1.08 to 1.33]; p = 0.001), followed by a model that also included LV mass (chi-square test, 17.1; p < 0.001). Traditional cardiovascular risk scores were not predictive of the adverse events.

CONCLUSIONS: Our findings reveal important prognostic associations of diffuse myocardial fibrosis and LV remodeling in PLWH. These results may support development of personalized approaches to screening and early intervention to reduce the burden of HF in PLWH (International T1 Multicenter Outcome Study; NCT03749343).

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. de Leuw P, Arendt CT, Haberl AE, et al. Myocardial Fibrosis and Inflammation by CMR Predict Cardiovascular Outcome in People Living With HIV. JACC Cardiovasc Imaging. 2021. PMID: 33865770. doi:10.1016/j.jcmg.2021.01.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。